Articles published by Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Late-Breaking Abstract and Poster Presentation on Positive Preclinical Data For TSHA-105 Demonstrating Therapeutic Potential for the Treatment of Epilepsy Caused by SLCA13A5 Deficiency

December 06, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming November Investor Healthcare Conferences

November 08, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Release Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10

November 03, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming Gene Therapy Summit

October 21, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Neuropathy (GAN) in Partnership with GeneDx as well as a Collaboration with Hereditary Neuropathy Foundation and Charcot-Marie-Tooth Association Centers of Excellence

October 13, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome

October 12, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-101 for the Treatment of Infantile GM2 Gangliosidosis

September 29, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming October Investor Healthcare Conferences

September 28, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Receives Orphan Drug Designation from the European Commission for TSHA-102 for the Treatment of Rett Syndrome

September 22, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Publication of Positive Preclinical Data for TSHA-104 Demonstrating Therapeutic Potential in SURF1-associated Leigh Syndrome in Journal Molecular Therapy: Methods & Clinical Development

September 15, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-102 for the Treatment of Rett Syndrome

September 08, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming September Investor Healthcare Conferences

September 01, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Receives Orphan Drug Designation for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency From the European Commission

August 25, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-118 for the Treatment of CLN1 Disease

August 17, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Secures up to $100 Million Non-Dilutive Term Loan Financing

August 16, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 16

August 09, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming August Investor Healthcare Conferences

August 02, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Manufacturing Day

July 20, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference

July 08, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Publication of Natural History Data for TSHA-120 in Giant Axonal Neuropathy in the Journal, Brain

June 21, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Virtual R&D Day

June 17, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum

June 15, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host First Annual Stockholder Meeting

June 10, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences

May 26, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Joins the Rare Disease Company Coalition

May 19, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development Officer

May 13, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences

May 12, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

May 11, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed Journal

May 10, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Multiple Data Presentations and Workshop Presentations at the 24th Annual Meeting of the American Society of Gene & Cell Therapy

May 05, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.